Ermir Xhihani RDH

Recommended Articles

• How Depression Leads to COPD Medication Non-Adherence

  Chronic Obstructive Pulmonary Disease (COPD) is a progressive disease that still does not have a cure. The World Health Organization predicts that COPD will become the fourth leading cause of death worldwide by 2030. The predominant cause for COPD is tobacco smoking. Most symptoms are irreversible,...

• What is a Mononucleosis Spot Test?

  Mononucleosis is often called the kissing disease. This is a viral infection transmitted through saliva and transferred through kissing. You can also be exposed through a cough, sneeze or by sharing a glass or food utensils with someone who has mononucleosis infection. But this is not as contagious...

• Under-Skin Transplants Hold Promise for Type 1 Diabetes Patients

  Type 1 diabetes, a disease that can radically alter how a person’s life will unfold right out of the womb, is an incurable condition that forces a patient to adapt to a new lifestyle. If they do not, they ultimately can face severe complications and extreme hardships as time goes on.The cause...

• Fibromyalgia: How Support Groups Can Help You

  It is shocking to know that currently it is projected that fibromyalgia affects 7% of the world’s population. The cries of fibromyalgia rent everywhere from blogs, online forums, Facebook posts, as well as in-person reports. So, what’s the major problem that is seen throughout? People with this...

• Century-Old Vaccine Gives Hope for Fibromyalgia Sufferers

  At last, there’s a likelihood for a more effective treatment for those suffering from fibromyalgia. A possible treatment that actually puts a stop to symptoms is on its way. It’s a most unexpected form but a familiar one to the medical community. The Bacille Calmett-Guerin vaccine or BCG is...

• New Cystic Fibrosis Treatment Shows Promise for those with a Specific Gene Mutation

  The data released on July 18th from three clinical trials conducted by Vertex Pharmaceuticals revealed promising results. The drugs that were tested in these trials are three different triple combination regimes that are designed to treat the underlying cause of cystic fibrosis in patients with the...